A detailed history of Ria Advisory Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ria Advisory Group LLC holds 2,360 shares of NVO stock, worth $206,854. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,360
Previous 2,545 7.27%
Holding current value
$206,854
Previous $327 Million 14.01%
% of portfolio
0.1%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$119.07 - $145.42 $22,027 - $26,902
-185 Reduced 7.27%
2,360 $281 Million
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $259,869 - $345,916
2,545 New
2,545 $327 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $136,319 - $299,110
1,499 Added 101.7%
2,973 $270 Million
Q2 2023

Jul 25, 2023

BUY
$155.98 - $172.65 $24,956 - $27,624
160 Added 12.18%
1,474 $239 Million
Q1 2023

Apr 25, 2023

BUY
$132.34 - $159.14 $173,894 - $209,109
1,314 New
1,314 $209 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ria Advisory Group LLC Portfolio

Follow Ria Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ria Advisory Group LLC with notifications on news.